"Ice": An old drug returns in its most powerful route;"Ice": Uma droga antiga que retorna ainda mais poderosa

Jornal Brasileiro de Psiquiatria

Volumn 50, Issue 1-2, 2001, Pages 57-62

  Nappo, Solange Aparecida ^a,b   Noto, Ana Regina ^a   Fernandes Galduróz, José Carlos ^a   De Araújo Carlini, Elisaldo Luiz ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b EPM Unifesp ^*  (Brazil)

Author keywords

"Ice"; Depenedence; Metamphetamine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CENTRAL STIMULANT AGENT; COCAINE; DECONGESTIVE AGENT; DOPAMINE; METHAMPHETAMINE; MONOAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

ALERTNESS; ANOREXIA; BRAZIL; CEREBROVASCULAR ACCIDENT; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG MECHANISM; ENERGY; EUPHORIA; FATIGUE; HEART INFARCTION; HUMAN; HYPERTENSION; INTELLECT; IRRITABILITY; PARANOIA; PERSONALITY DISORDER; PHYSICAL PERFORMANCE; PSYCHOSIS; REVIEW; SELF ESTEEM; SEXUALITY; SMOKING; SOMNOLENCE; TACHYCARDIA; VIOLENCE; WAKEFULNESS;

EID: 19744368564     PISSN: 00472085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Amara, S.G. & Sonders, M.S. Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend., 51: 87-96, 1998.
2. Asghar, K. Pharmacology and toxicology of Amphetamine and related designer drugs. USA: National Institute on Drug Abuse, 1989.
3. Beebe, K. & Walley, E. Smokeable methamphetamine ("Ice"): An old drug in a different form. Am. Fam. Physician., 51: 449-53, 1995.
4. Bannon, M.J., Granneman, J.G. & Kapatos, G. The Dopamine transporter. In: Bloom, F.E. & Kupfer, D.J. Psychopharmacology. The fourth generation of progress. New York: Raven Press, 1994, pp. 179-188.
5. Cavalcanti, C.T. Notas sobre o abuso das anfetaminas - Seus perigos e prevenção. Neurobiologia, 21: 85-91, 1958.
6. Cho, K.A. Ice: A new dosage form of an old drug. Science, 249: 631-34, 1990.
7. Cho, A.K. & Segal, D.S. Amphetamines and its analogs. USA: Academic Press, 1994.
8. Cook, E.G. et al. Pharmacokinetics of Methamphetamine-HCl self-administered to human subjects by smoking s-(+)-methamphetamine-HCl. Drug Met. Disp., 21: 717-23, 1993.
9. Ellinwood, E.H. & Nikaido, A.M. Stimulant induced impairment: a perspective across dose and duration of use. Alcohol, Drugs and Driving, 3: 19-24, 1987.
10. Fasciano, J.; Hatzidimitriou, G.; Yuan, J.; Katz, J.L. & Ricaurte, G. N-Methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects. Brain Res., 771: 115-20, 1997.
11. Frawley, P.J. & Smith, J.W. One-year follow-up after multimodal inpatient treatment for cocaine and methamphetamine dependencies. J. Substance Abuse, 9: 271-86, 1992.
12. Frey, K.; Kilbourn, M. & Robinson, T. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur. J. Pharmacol., 334: 273-79, 1997.
13. Galduróz, J.C.R; Noto, A.R.; Nappo, A.S. & Carlini, E.A. I Levantamento Domiciliar National sobre o Uso de Drogas Psicotrópicas. São Paulo: Cebrid, 1999.
14. Galduróz, J.C.F.; Noto, A.R. & Carlini, E.A. IV Levantamento sobre o Uso de Drogas entre Estudantes de 1o e 2o Graus em 10 Capitals Brasileiras. São Paulo: Cebrid, 1997.
15. Glittenberg, J. & Anderson, C. Methamphetamines: Use and trafficking in the Tucson-Nogales area. Sub Use Mis., 34: 1977-1989, 1999.
16. Hong, R.; Matsuyama, E. & Nur, K. Cardiomyopathy associated with the smoking of crystal methamphetamine. Jama, 265: 1152-154, 1991.
17. International Narcotics Control Board. Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances. Vienna: United Nations Publications, 1998.
18. Kanof, P. Methamphetamine: drug action and consequences. Unpublished presentation at the Summit Meeting on Methamphetamine, Phoenix, AZ, May 17, 1996.
19. Kramer, J.C.; Fishman, V.S. & Littlefield, D.C. Amphetamine abuse. Jama, 207: 89-93, 1967.
20. Logan, B.K.; Fligner, C.L. & Haddix, T. Cause and manner of death in fatalities involving methamphetamine. J. Forensic Sci., 43: 28-34, 1991.
21. Marwick, C. NIDA seeking data on effect of fetal exposure to Methamphetamine. Jama, 283: 2225-226, 2000.
22. Meng, Y.; Margozata, D.; Bridgen, D.T.; Martin, B.R.; & Lichtman, A.H. Pharmacological effects of Methamphetamine and other stimulants via inhalation exposure. Drug Alcohol Depend., 53: 11-120, 1999.
23. Molitor, F.; Truax, S.R.; Ruiz, J.D. & Sun, R.K. Association of Methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J. Med., 168: 93-97, 1998.
24. Nakatani, Y. & Hara, T. Disturbance of consciousness due to Methamphetamine abuse. Psychopathology, 31: 131-37, 1997.
25. National Institute on Drug Abuse. Methamphetamine: Abuse and addiction. In: Research Report Series. (http://165.112.78.61/ResearchReports/methamph/ methamph2.html) 2000.
26. Perez-Reyes, M. et al. Clinical effects of Methamphetamine-HCl vapor inhalation. Life Sci., 49: 953-59, 1991.
27. Ribas, J.C. Aspectos clínicos e sociais do anfetaminismo. Folha Médica, 64: 491-94, 1972.
28. Richards, J.R.; Johnson, E.B.; Stark, R.W. & Derlet, R.W. Methamphetamine abuse and rhabdomyolisis in the ED: A 5-year study. Am. J. Emerg. Med., 17(7): 681-85, 1999.
29. Scares, L.P.; Westra, S. & Barone, J.A. Illegal use of drugs: a current review. US Pharmacist., 15: 17-39, 1990.
30. Silva, O.A.; Yonamine, M. & Reinhardt, V.E.D. Identificaç ão de 3,4-metilenodioximetanfetamina (MDMA) e compostos relaclonados por cromatografia em fase gasosa e espectrometria de massas em comprimido de ecstasy apreendidos em São Paulo. Rev. Farm. Bioquím. Univ. São Paulo, 34: 33-37, 1998.
31. Smith, D.E. & Fischer, C.M. An analysis of 310 cases of acute high dose Methamphetamine toxicity in Haight-Ashbury. Clin. Toxicol., 3(1): 117-24, 1970.
32. Spotts, J.V. & Spotts, C.A. Use and abuse of Amphetamines and its substitutes. USA: National Institute on Drug Abuse, 1990.
33. Tamura, M. Japan: stimulant epidemics past and present. Bull. Narc., 41: 83-93, 1989.
34. Wolffenbuttel, E. Uso e abuso de Pervitin. Rev. Bras. Med., 20: 166, 1963.
35. World Health Organization (Programme on Substance Abuse). Amphetamine-type stimulants. Geneva: WHO, 1997.
36. Yui, K.; Goto, K.; Shigenori, I. & Ishiguro, T. Methamphetamine psychosis: Spontaneous recurrence of paranoid-hallucinatory states and monoamlne neurotransmitter function. J Clin. Psychopharmacol., 17: 34-43, 1997.